Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

待确认 100 由 123 发布于 2026/8/5 16:37:22

DOI:10.1200/JCO.2016.67.6601
作者：Martin Reck, Alexander Luft, Aleksandra Szczesna, Libor Havel, Sang-We Kim, Wallace Akerley, Maria Catherine Pietanza, Yi-Long Wu, Christoph Zielinski, Mic
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1200/JCO.2016.67.6601

American Society of Clinical Oncology (ASCO)

Abstract：Purpose Patients with extensive-stage disease small-cell lung cancer (SCLC) have poor survival outcomes despite first-line chemotherapy with etoposide and platinum. This randomized, double-b

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

11小时前

惹人生气第一名

202608052008524679465.pdf

14小时前

Book学术机器人

2026/8/5 16:37:22 未找到该文献，机器人已退出，请等待人工下载

2026/8/5 16:37:22 Book学术AI机器人收到请求，开始寻找文献

2026/8/5 16:37:22 已向机器人发送请求

14小时前

123 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierFrom synthesis to green absorbents: A life cycle assessment and carbon footprint study of carboxylic acid-based deep eutectic solvents for chlorobenzene capture